Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Working paper
Research output: Working paper
}
TY - UNPB
T1 - WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus
AU - Wilkinson, Dianna
AU - Page, M.
AU - Almond, Neil
AU - Anderson, Robert
AU - Berry, Neil
AU - Dougall, Thomas
AU - Efstathiou, Stacey
AU - Hassall, Mark
AU - Mattiuzzo, Giada
AU - Peter, Rigsby
AU - Rose, N.
AU - Schepelmann, Silke
AU - Stone, Lindsay
AU - Minor, Philip D.
AU - Labrosse, Beatrice
AU - Leculier, Christophe
AU - Pannetier, Delphine
AU - Strecker, Thomas
AU - Krahling, Verena
AU - Schnierle, Barbara
AU - Capobianchi, Maria
AU - Castilletti, Concetta
AU - Gatherer, Derek
AU - Bishop, Lisa
AU - Hartman, Katharina
AU - Lauder, Robert
AU - Wright, Edward
AU - Tedder, Richard
AU - Samuel, Dhan
AU - Dicks, Steve
AU - Rudge, Thomas
AU - Simmons, Graham
AU - Kaplan, Gerardo
AU - Khuran, Surender
AU - Weiss, Carol D.
AU - Hogrefe, Wayne
AU - Rodriguez, Nicole
AU - Hsu, Allen
AU - Honko, Anna N.
AU - Bennett, Richard S.
AU - Pettitt, Jamie
AU - Janosko, Krisztina
AU - Marchand, Jonathan
AU - Postnikova, Elena
AU - Wu, Hua
AU - Griffiths, Anthony
AU - Hooper, Jay W.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - In support of the WHO response to the Ebola crisis, NIBSC is undertaking a project to develop an International Standard for use in the calibration and control of Ebola antibody assays. The availability of International Standards (IS) for antibodies would facilitate the standardization of Ebola serological methods used in epidemiological studies to measure past or present Ebola virus disease and in vaccinology studies to measure antibodies elicited by vaccination in humans. In the absence of such standards, individual laboratories apply their own reference standards which are not harmonized with other laboratories and methods and thus cannot serve to improve the reproducibility between laboratories. Recommendations made by participants attending the Technical Workshop on the Standardisation of Serological and PCR assays for the detection of Ebola virus (NIBSC, UK, 5-6 March 2015), included the urgent prioritization of the development of an interim Ebola standard for serology assays while perusing the longer-term goal of establishing an International Standard according to published WHO guidelines and formally endorsed by the WHO Expert Committee on Biological Standardization (ECBS). This report describes the development and worldwide collaborative study evaluation of a panel of candidate Ebola antibody preparations for the selection of the most appropriate candidate to serve as the interim WHO standard for Ebola antibody assays.
AB - In support of the WHO response to the Ebola crisis, NIBSC is undertaking a project to develop an International Standard for use in the calibration and control of Ebola antibody assays. The availability of International Standards (IS) for antibodies would facilitate the standardization of Ebola serological methods used in epidemiological studies to measure past or present Ebola virus disease and in vaccinology studies to measure antibodies elicited by vaccination in humans. In the absence of such standards, individual laboratories apply their own reference standards which are not harmonized with other laboratories and methods and thus cannot serve to improve the reproducibility between laboratories. Recommendations made by participants attending the Technical Workshop on the Standardisation of Serological and PCR assays for the detection of Ebola virus (NIBSC, UK, 5-6 March 2015), included the urgent prioritization of the development of an interim Ebola standard for serology assays while perusing the longer-term goal of establishing an International Standard according to published WHO guidelines and formally endorsed by the WHO Expert Committee on Biological Standardization (ECBS). This report describes the development and worldwide collaborative study evaluation of a panel of candidate Ebola antibody preparations for the selection of the most appropriate candidate to serve as the interim WHO standard for Ebola antibody assays.
KW - Ebola
KW - diagnostics
KW - Western blotting
KW - ELISA
KW - filovirus
KW - Ebolavirus
KW - Filoviridae
M3 - Working paper
VL - WHO/BS/2015.2275Ab
BT - WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus
PB - World Health Organization
CY - Geneva
ER -